The Levels of Anaesthetics in Heart Muscle During Heart Surgery
Information source: University of Edinburgh
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cardiac Surgery
Intervention: Blood samples (Biological)
Phase: N/A
Status: Not yet recruiting
Sponsored by: University of Edinburgh Official(s) and/or principal investigator(s): R Peter Alston, MB ChB, Principal Investigator, Affiliation: NHS Lothian
Overall contact: Ka Ting Ng, Student, Phone: +447519692960, Email: s1464996@sms.ed.ac.uk
Summary
In the last few years, anaesthetic agents, Isoflurane used in heart surgery have shown some
benefits to reduce the risk of heart muscle damage. Many research studies have been
conducted to reveal the benefit relationship between Isoflurane and the risk of heart muscle
injury during heart surgery. However, there is a knowledge gap regarding the optimal level
of Isoflurane concentration to confer the benefit of heart muscle-protective properties.
Therefore, this study is conducted to answer that question by measuring the Isoflurane
concentration in the blood vessels. It also assesses whether Isoflurane concentration in the
blood is correlated to the oxygenator exhaust level of Isoflurane in the heart-lung machine.
Clinical Details
Official title: Coronary Sinus Blood Isoflurane Concentration in Patients Undergoing Heart Surgery
Study design: Observational Model: Cohort, Time Perspective: Cross-Sectional
Primary outcome: Levels of Isoflurane in coronary sinus blood
Secondary outcome: Isoflurane level in oxygenator exhaust levels on heart-lung machine
Detailed description:
All patients who scheduled for an elective heart surgery in Royal Infirmary of Edinburgh
using a heart-lung machine and the administration of ether-like anaesthetic, isoflurane will
be recruited in this study. This is a pilot study to determine the concentration of
isoflurane in heart muscle. Isaac and Michael (2005), Hill (1998), Julious (2005) have
conducted survey/research to conclude that 30 sample sizes are adequate for a pilot study.
Thus, investigators aim to recruit at least 30 sample sizes to allow data (standard
deviation, mean etc.) used in sample size estimation for future studies.
The medical and surgical care plans for participants remain as usual in this study. In a
normal practise, surgeons will insert a catheter into the blood vessels coming from the
heart to deliver solution to stop the contraction of heart for heart procedure. At this
moment, two blood samples of about two-teaspoonful in volume will be collected from the
in-placed catheters in vein and aorta. Then, the blood samples will be sent to lab to
measure the concentration of isoflurane in vein and aorta. Also, the reading of exhausted
isoflurane gas on heart-lung machine are routinely monitored and recorded.
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Age 18 years or older
- Scheduled for elective cardiac surgery requiring cardiopulmonary bypass.
- Anaesthetised using isoflurane as part of a balanced anaesthetic technique during
heart-lung machine
- Patient has consented to participate
- Cardioplegia technique involves insertion of a coronary sinus catheter.
Exclusion Criteria:
- Emergency surgery or patient with malignancy
- Heart surgery undertaken without heart-lung machine
- Age younger than 18 years
- Unable or unwilling to provide informed consent
- Cardiac surgery that does not require cardiopulmonary bypass
- Anaesthetised using an total intravenous-based technique
Locations and Contacts
Ka Ting Ng, Student, Phone: +447519692960, Email: s1464996@sms.ed.ac.uk Additional Information
Statistic number of patients undergoing heart surgery in the United Kingdom
Related publications: Yau JM, Alexander JH, Hafley G, Mahaffey KW, Mack MJ, Kouchoukos N, Goyal A, Peterson ED, Gibson CM, Califf RM, Harrington RA, Ferguson TB; PREVENT IV Investigators. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV). Am J Cardiol. 2008 Sep 1;102(5):546-51. doi: 10.1016/j.amjcard.2008.04.069. Epub 2008 Jul 2. BIGELOW WG, LINDSAY WK, GREENWOOD WF. Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg. 1950 Nov;132(5):849-66. Yoshimi I. Cardiac preconditioning by anesthetic agents: roles of volatile anesthetics and opioids in cardioprotection. Yonago Acta Medica 2007; 50: 45-55. Hausenloy DJ, Boston-Griffiths E, Yellon DM. Cardioprotection during cardiac surgery. Cardiovasc Res. 2012 May 1;94(2):253-65. doi: 10.1093/cvr/cvs131. Epub 2012 Mar 22. Review. R. Peter Alston, Paul Myles, Marco Ranucci. Oxford Textbook of Cardiothoracic Anaesthesia. Oxford University Press 2015. Chapter 15 Myocardial protection during cardiac surgery. 157-65. Pramood CK, Reena S, Gajraj SS. Ischemic and anesthetic preconditioning of the heart: an insight into the concepts and mechanisms. Journal Indian Academy of Clinical Medicine; 2005; 6(1): 45-7 Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth. 2006 Aug;97(2):127-36. Epub 2006 Jun 21. Review. Fabien Picard, Francis Depret, Sergio ZC, Steven Hollenberg. Effect of anesthesia level on murine cardiac function. F1000 Research 2014; 3: 165-72 Chiu-Fen Y, Michael Yu-Chih C, Tsung-I C, Ching-Feng Cheng. Dose-dependent effects of isoflurane on cardiovascular function in rats. Tzu Chi Medical Journal 2014; 26 (3): 119-22
Starting date: September 2015
Last updated: June 11, 2015
|